These molecules modulate CS in COVID-19, notably meloxicam, which exhibited a downregulatory effect on cytokines (IL-6, CCL2, GM-CSF, CXCL10, IL-2, and TNF-α) [147]. This evidence concerns the gene CSF2 and COVID-19.